Form 10-Q · Quarterly report
Nasdaq, Inc. 10-Q, filed Oct 22, 2026
- Filed
- CIK
- 0001120193
- Accession no.
- 0001120193-26-000020
Summary
Nasdaq, Inc. reported third-quarter 2026 revenue less transaction-based expenses of $1.48 billion, up 12.6% from a year earlier, with net income attributable to Nasdaq of $540 million, up 27.8%, and diluted earnings per share of $0.96. The quarter included 15 new operating company listings on its U.S. exchanges that raised $32 billion, and record index net inflows of $141 billion over the trailing twelve months, including $49 billion in the quarter.
Key points
- Nasdaq's third-quarter revenue less transaction-based expenses rose 12.6% year over year to $1.481 billion, with operating income of $732 million, up 24.9%.
- Nasdaq declared a quarterly cash dividend of $0.31 per common share, up 14.8% from $0.27 a year earlier.
- Financial Technology segment revenue grew 16% and annual recurring revenue grew 18%, with 54 new clients, 5 cross-sells and 135 upsells signed in the quarter.
- End-of-period assets under management in exchange-traded products tracking Nasdaq indices reached a record $1.2 trillion, with quarterly average ETP AUM of $1.1 trillion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion EXECUTIVE OVERVIEW Nasdaq is a leading technology platform that powers the world’s economies. We architect the infrastructure of the world’s most modern markets, power the innovation economy, and build trust in the financial system. We empower economic opportunity by designing and deploying advanced technology, data, and intelligence solutions that enable our clients to capture opportunities, navigate risk, and strengthen resilience. Our organizational structure aligns our businesses with the foundational shifts that are driving the evolution of the global financial system. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.